Darran O'Connor
Darran O'Connor
Verified email at rcsi.ie
Title
Cited by
Cited by
Year
Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction
LT Allen, M Tosetto, IS Miller, DP O’Connor, SC Penney, I Lynch, ...
Biomaterials 27 (16), 3096-3108, 2006
2442006
Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
DJ Brennan, DP O'connor, E Rexhepaj, F Ponten, WM Gallagher
Nature Reviews Cancer 10 (9), 605-617, 2010
2102010
miRNA dysregulation in breast cancer
L Mulrane, SF McGee, WM Gallagher, DP O'Connor
Cancer research 73 (22), 6554-6562, 2013
1962013
p53 as a target for the treatment of cancer
MJ Duffy, NC Synnott, PM McGowan, J Crown, D O’Connor, ...
Cancer treatment reviews 40 (10), 1153-1160, 2014
1942014
Monounsaturated fatty acid–enriched high-fat diets impede adipose NLRP3 inflammasome–mediated IL-1β secretion and insulin resistance despite obesity
OM Finucane, CL Lyons, AM Murphy, CM Reynolds, R Klinger, NP Healy, ...
Diabetes 64 (6), 2116-2128, 2015
1902015
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas
K Magnusson, M de Wit, DJ Brennan, LB Johnson, SF McGee, ...
The American journal of surgical pathology 35 (7), 937-948, 2011
1862011
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
AJ O'Neill, M Prencipe, C Dowling, Y Fan, L Mulrane, WM Gallagher, ...
Molecular cancer 10 (1), 1-13, 2011
1612011
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ...
Scientific reports 6 (1), 1-13, 2016
1402016
Molecular links between mammary gland development and breast cancer
F Lanigan, D O'connor, F Martin, WM Gallagher
Cellular and molecular life sciences: CMLS 64 (24), 3159-3184, 2007
1292007
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer
DJ Brennan, E Rexhepaj, SL O'Brien, E McSherry, DP O'Connor, A Fagan, ...
Clinical Cancer Research 14 (9), 2681-2689, 2008
1102008
The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer
DJ Brennan, S Ek, E Doyle, T Drew, M Foley, G Flannelly, DP O’Connor, ...
European journal of cancer 45 (8), 1510-1517, 2009
892009
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
Å EhlÚn, DJ Brennan, B Nodin, DP O'connor, J Eberhard, ...
Journal of translational medicine 8 (1), 1-12, 2010
862010
miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro
L Mulrane, SF Madden, DJ Brennan, G Gremel, SF McGee, S McNally, ...
Clinical cancer research 18 (24), 6702-6713, 2012
782012
DNA‐damage‐responsive acetylation of pRb regulates binding to E2F‐1
D Markham, S Munro, J Soloway, DP O'Connor, NB La Thangue
EMBO reports 7 (2), 192-198, 2006
722006
A new effector pathway links ATM kinase with the DNA damage response
C Demonacos, M Krstic-Demonacos, L Smith, D Xu, DP O'Connor, ...
Nature cell biology 6 (10), 968-976, 2004
692004
Molecular basis of cell–biomaterial interaction: Insights gained from transcriptomic and proteomic studies
WM Gallagher, I Lynch, LT Allen, I Miller, SC Penney, DP O’Connor, ...
Biomaterials 27 (35), 5871-5882, 2006
672006
Mutant p53: a novel target for the treatment of patients with triple‐negative breast cancer?
NC Synnott, A Murray, PM McGowan, M Kiely, PA Kiely, N O'donovan, ...
International journal of cancer 140 (1), 234-246, 2017
652017
p53 codon 72 polymorphism and human papillomavirus associated skin cancer
DP O'Connor, EW Kay, M Leader, GJ Atkins, GM Murphy, M Mabruk
Journal of clinical pathology 54 (7), 539-542, 2001
652001
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
B Nodin, H Johannesson, S Wangefjord, DP O’Connor, KE Lindquist, ...
Diagnostic pathology 7 (1), 1-9, 2012
632012
Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
E Rexhepaj, K Jirstrom, DP O'Connor, SL O'Brien, G Landberg, MJ Duffy, ...
BMC cancer 10 (1), 1-12, 2010
612010
The system can't perform the operation now. Try again later.
Articles 1–20